Establishing Rules of the Road for Pharmaceutical Representatives
Being up-front can help prevent back-door tactics.
Fam Pract Manag. 2005 Mar;12(3):10-12.
Interactions with pharmaceutical representatives often evoke mixed feelings for many physicians. On one hand, reps can provide us with useful information on new drugs and new study results, indications, contraindications and recalls. They also provide samples that benefit our patients. On the other hand, they may take up more time than we have available, and they may employ high-pressure sales techniques. This conflict had been building at my office to the point where I was ready to stop seeing them altogether.
Although I couldn’t speak for my partners, I wrote the reps an open letter and posted multiple copies in my sample and break rooms. So far the response has been better than imagined. Many reps have told me they appreciate knowing my expectations. If the letter offended any, they’ve kept it a secret. Some have found it hard to leave all of their high-pressure techniques behind, but our interactions have improved overall.
Feel free to adapt the letter for your own use. You can download a version below that is suitable for printing or a Word file that can be modified according to your preferences.
Dear Pharmaceutical Representatives,
We’re seeing a lot of new faces here lately. To maximize my time, minimize my frustration and demonstrate to my patients that drug companies do not influence my opinions, I have written down some helpful tips that I hope will guide our interactions and optimize our relationship.
How to Sell Pills Without Becoming One: A Guide for Pharmaceutical Representatives
Do tell me why you think your drug is exceptional. Use the STEPS approach, describing the Safety, Tolerability, Efficacy, Price and Simplicity of your drug.
Don’t say negative things about your competitors or their drugs. Tell me why your product is superior, not just passable. Telling me that your drug is better than a bad drug is not exactly a glowing endorsement.
Do tell me why the cost of your drug is a better value than generics in its class. Compare the cost to your brand-name competitors only if there are no acceptable generics in your drug’s class.
Do keep me updated on the formulary and tier status of your drugs. This is often more important than your cash price because a high-tiered drug may cost my patient six to 10 times the generic price or two to three times the price of a preferred brand-name drug.
Do show me patient education materials about diseases your drugs treat. But please omit drug names, logos, icons or mascots. Including the company name in small type is acceptable. My goal is to distribute information, not propaganda.
Do ask me to sign for samples. I use them to test your drugs on my patients before they buy them, or to help them deal with the expense of your drugs when they can’t afford them.
Don’t tell me how much another physician in the area uses your drug or how he or she uses it off-label.
Do arrange for other specialists to come to our office during lunch, and let me pick their brains.
Don’t tell me that you use databases to profile my prescribing habits. I know it happens, but I am not comfortable becoming a demographic target in your marketing efforts.
Don’t ask me what I prescribe or why I prescribe it. This makes me feel like you are collecting marketing information and trying to debate my prescription choices.
Don’t bother inviting me to evening dinner presentations. I don’t need extra reasons to spend time away from my family.
Don’t expect me to stay long in the sample room. My schedule is very tight, and I don’t like to keep patients waiting. I’ll stay long enough to sign and leave.
Don’t expect me to spend more than 15 minutes at lunch, if I join you at all. Eating the lunch you provide often saves me time, which means I can get back to taking care of my patients and get home to my family sooner.
Do feel free to talk about the weather, movies, current events or other small talk. Just realize that my time is limited and we will have a smaller window in which to discuss your drug.
Don’t comment on how long it has been since you’ve had a chance to talk to me. I will try to give you some time in a busy day of seeing patients, but the guilt trip makes me want to give you even less of my time.
Don’t give me anything to read later. I have more than enough to read already and am capable of doing my own research if interested.
Don’t ask me to prescribe your drug or whether I will prescribe it. I make that decision on a case-by-case basis with my patients.
Don’t offer me pens, notepads or any other “freebies.” The cost of these items is included in your company’s budget, which influences the price you charge my patients for your drugs. I’d rather you pass along savings than pens.
My goal is to provide my patients with the best, most affordable health care possible. Your goal is to sell drugs. I hope by following the above guidelines we’ll be able to leave our encounter feeling like our time together helped both of us to further our goals.
WHAT DO YOU THINK?
The views and opinions expressed in the editorials published in Family Practice Management do not necessarily represent those of FPM or our publisher, the American Academy of Family Physicians. We recognize that your point of view may differ from the author’s, and we encourage you to share it. Please send your comments to FPM via e-mail at firstname.lastname@example.org or overland to 11400 Tomahawk Creek Parkway, Leawood, Kansas 66211–2672.
Copyright © 2005 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in FPM
Related Topic Searches
MOST RECENT ISSUE
Access the latest issue
of FPM journal
THE NEW E/M CODING RULES
Learn more with these articles from FPM journal: